In contrast, reduced NOL7 expression was related to favorable OS in bladder carcinoma (p < 0.05), KIRC (p < 0.01), ovarian cancer (p < 0.001), and READ (p < 0.001). Here, NOL7 is linked to ovarian carcinoma.